<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE339nnn/GSE339142/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE339142</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Fibronectin inhibition restores myelination in endothelial TNFR2-depedent non-remitting Experimental Autoimmune Encephalomyelitis [snRNA-Seq]</name><description>Multiple Sclerosis (MS) is characterized by impaired remyelination and progressive neurodegeneration. We investigated the mechanisms underlying remyelination failure in Experimental Autoimmune Encephalomyelitis (EAE), a murine model of MS. TNFR2 deletion induces a severe non-remitting disease course and the main aim was to identify the cell population that drives this phenomenon. Through the analysis of single-nucleus RNA sequencing datasets, we identified endothelial cell-specific TNFR2 ablation as a driver of impaired remyelination. This effect was associated with fibronectin overexpression and accumulation in demyelinating lesions, highlighting the critical role of endothelial-specific TNFR2 signaling in central nervous system repair.</description><dates><publication>2026/09/07</publication></dates><accession>GSE339142</accession><cross_references><GSM>GSM9889062</GSM><GSM>GSM9889061</GSM><GSM>GSM9889060</GSM><GSM>GSM9889063</GSM><GSM>GSM9889059</GSM><GSM>GSM9889058</GSM><GPL>28457</GPL><GSE>339142</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>